CPI appoints new Director of HealthTech

CPI, an independent deep tech innovation centre part of the High Value Manufacturing Catapult, has appointed Rahul Kapoor as its first HealthTech Director.

Kapoor has extensive commercial HealthTech experience from his previous roles at Johnson & Johnson, Janssen, Unilever and digital health SME, Medic Spot Ltd.

Under Kapoor’s leadership, CPI will continue to support companies in commercialising innovative health technologies.

Kapoor will lead the transformation of CPI’s role in HealthTech to boost partnerships across the value-chain, and ensure the sector benefits from CPI’s services and expansive scale-up capabilities to provide system-wide solutions to the product design, development, clinical validation and adoption of novel health technologies.

The appointment marks CPI’s shift towards HealthTech and ‘reinforces the organisation’s commitment to improving global population health and the cost-effectiveness of health and social care through innovation, both nationally and globally,’ the company said.

CPI works with and connects actors from across the HealthTech ecosystem – from start-ups, SMEs and large corporations, to investors, government, regulators, and industry bodies – to speed up the new product development journey through access to funding, investment and support with regulation, product design and clinical trials.

Offering multi-disciplinary innovation development and scale-up capabilities across digital, electronics, photonics, formulation, nanotechnologies, materials, biotechnology and biologics – CPI works closely with its partners to address innovation gaps by developing and scaling-up components and sub-systems making up HealthTech products.

Dr Arun Harish, Strategy Director at CPI, said:

“CPI has set itself the challenge of improving global health and bringing down the cost of healthcare through innovation.

“As we focus on speeding up product development and boosting disruptive innovation, Rahul’s appointment is a key part of our journey towards becoming a globally recognised innovation organisation with unique and cutting-edge HealthTech capabilities.”